Galactomannan in piperacillin-tazobactam: How much and to what extent?

[1] Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (06) : 917 - 920

[2] LATGE JP, 1994, INFECT IMMUN, V62, P5424

[3] Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation [J]. BLOOD, 2001, 97 (06) : 1604 - 1610

[4] MENNINKKERSTEN MAS, 2004, LAT BREAK ABSTR PROG, P17

[5] Lack of evidence that false-positive Aspergillus galactomannan antigen test results are due to treatment with piperacillin-tazobactam [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (09) : 1401 - 1402

[6] Reactivity of Platelia Aspergillus galactomannan antigen with piperacillin-tazobactam:: Clinical implications based on achievable concentrations in serum [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) : 1989 - 1992

[7] A NEW SENSITIVE SANDWICH ENZYME-LINKED-IMMUNOSORBENT-ASSAY TO DETECT GALACTOFURAN IN PATIENTS WITH INVASIVE ASPERGILLOSIS [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (02) : 497 - 500

[8] False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (24) : 2366 - 2367

[9] METHODOLOGICAL ISSUES IN ASSESSING REPRODUCIBILITY - A COMPARATIVE-STUDY OF VARIOUS INDEXES OF REPRODUCIBILITY APPLIED TO REPEAT ELISA SEROLOGIC TESTS FOR LYME-DISEASE [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1995, 48 (09) : 1123 - 1132

[10] False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (06) : 913 - 916

[1] Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (06) : 917 - 920

[2] LATGE JP, 1994, INFECT IMMUN, V62, P5424

[3] Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation [J]. BLOOD, 2001, 97 (06) : 1604 - 1610

[4] MENNINKKERSTEN MAS, 2004, LAT BREAK ABSTR PROG, P17

[5] Lack of evidence that false-positive Aspergillus galactomannan antigen test results are due to treatment with piperacillin-tazobactam [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (09) : 1401 - 1402

[6] Reactivity of Platelia Aspergillus galactomannan antigen with piperacillin-tazobactam:: Clinical implications based on achievable concentrations in serum [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) : 1989 - 1992

[7] A NEW SENSITIVE SANDWICH ENZYME-LINKED-IMMUNOSORBENT-ASSAY TO DETECT GALACTOFURAN IN PATIENTS WITH INVASIVE ASPERGILLOSIS [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (02) : 497 - 500

[8] False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (24) : 2366 - 2367

[9] METHODOLOGICAL ISSUES IN ASSESSING REPRODUCIBILITY - A COMPARATIVE-STUDY OF VARIOUS INDEXES OF REPRODUCIBILITY APPLIED TO REPEAT ELISA SEROLOGIC TESTS FOR LYME-DISEASE [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1995, 48 (09) : 1123 - 1132

[10] False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (06) : 913 - 916